SA66 Patient Demographic and Clinical Characteristics Associated With the Use of the Newly Approved Disease-Modifying Medications for Sickle Cell Disease
Jun 1, 2024, 00:00 AM
10.1016/j.jval.2024.03.1913
https://www.valueinhealthjournal.com/article/S1098-3015(24)02028-X/fulltext
Section Title :
Section Order :
11559
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(24)02028-X&doi=10.1016/j.jval.2024.03.1913